BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 34503107)

  • 1. Genomic and Transcriptomic Characteristics of Esophageal Adenocarcinoma.
    Hoppe S; Jonas C; Wenzel MC; Velazquez Camacho O; Arolt C; Zhao Y; Büttner R; Quaas A; Plum PS; Hillmer AM
    Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Genomic Profiling of Advanced Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas Reveals Similarities and Differences.
    Wang K; Johnson A; Ali SM; Klempner SJ; Bekaii-Saab T; Vacirca JL; Khaira D; Yelensky R; Chmielecki J; Elvin JA; Lipson D; Miller VA; Stephens PJ; Ross JS
    Oncologist; 2015 Oct; 20(10):1132-9. PubMed ID: 26336083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct esophageal adenocarcinoma molecular subtype has subtype-specific gene expression and mutation patterns.
    Guo X; Tang Y; Zhu W
    BMC Genomics; 2018 Oct; 19(1):769. PubMed ID: 30355311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complex structural rearrangements are present in high-grade dysplastic Barrett's oesophagus samples.
    Newell F; Patel K; Gartside M; Krause L; Brosda S; Aoude LG; Loffler KA; Bonazzi VF; Patch AM; Kazakoff SH; Holmes O; Xu Q; Wood S; Leonard C; Lampe G; Lord RV; Whiteman DC; Pearson JV; Nones K; Waddell N; Barbour AP
    BMC Med Genomics; 2019 Feb; 12(1):31. PubMed ID: 30717762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Mutational Testing of Preneoplastic Barrett's Mucosa by Next-Generation Sequencing of Formalin-Fixed, Paraffin-Embedded Endoscopic Samples for Detection of Concurrent Dysplasia and Adenocarcinoma in Barrett's Esophagus.
    Del Portillo A; Lagana SM; Yao Y; Uehara T; Jhala N; Ganguly T; Nagy P; Gutierrez J; Luna A; Abrams J; Liu Y; Brand R; Sepulveda JL; Falk GW; Sepulveda AR
    J Mol Diagn; 2015 Jul; 17(4):412-9. PubMed ID: 26068095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Evolution of Metaplasia to Adenocarcinoma in the Esophagus.
    Grady WM; Yu M
    Dig Dis Sci; 2018 Aug; 63(8):2059-2069. PubMed ID: 29766388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms.
    Reavis KM; Morris CD; Gopal DV; Hunter JG; Jobe BA
    Ann Surg; 2004 Jun; 239(6):849-56; discussion 856-8. PubMed ID: 15166964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene Expression in Barrett's Esophagus Cell Lines Resemble Esophageal Squamous Cell Carcinoma Instead of Esophageal Adenocarcinoma.
    Panda A; Bhanot G; Ganesan S; Bajpai M
    Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similarity of aberrant DNA methylation in Barrett's esophagus and esophageal adenocarcinoma.
    Smith E; De Young NJ; Pavey SJ; Hayward NK; Nancarrow DJ; Whiteman DC; Smithers BM; Ruszkiewicz AR; Clouston AD; Gotley DC; Devitt PG; Jamieson GG; Drew PA
    Mol Cancer; 2008 Oct; 7():75. PubMed ID: 18831746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic Obstructive Pulmonary Disease and the Risk of Esophagitis, Barrett's Esophagus, and Esophageal Adenocarcinoma: A Primary Care Case-Control Study.
    Menon S; Nightingale P; Trudgill N
    J Clin Gastroenterol; 2019; 53(10):e451-e455. PubMed ID: 31008868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic similarity between gastroesophageal junction and esophageal Barrett's adenocarcinomas.
    Ferrer-Torres D; Nancarrow DJ; Kuick R; Thomas DG; Nadal E; Lin J; Chang AC; Reddy RM; Orringer MB; Taylor JM; Wang TD; Beer DG
    Oncotarget; 2016 Aug; 7(34):54867-54882. PubMed ID: 27363029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Esophageal Cancer: Genomic and Molecular Characterization, Stem Cell Compartment and Clonal Evolution.
    Testa U; Castelli G; Pelosi E
    Medicines (Basel); 2017 Sep; 4(3):. PubMed ID: 28930282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypermethylation of the AKAP12 promoter is a biomarker of Barrett's-associated esophageal neoplastic progression.
    Jin Z; Hamilton JP; Yang J; Mori Y; Olaru A; Sato F; Ito T; Kan T; Cheng Y; Paun B; David S; Beer DG; Agarwal R; Abraham JM; Meltzer SJ
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):111-7. PubMed ID: 18199717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subtypes of Barrett's oesophagus and oesophageal adenocarcinoma based on genome-wide methylation analysis.
    Yu M; Maden SK; Stachler M; Kaz AM; Ayers J; Guo Y; Carter KT; Willbanks A; Heinzerling TJ; O'Leary RM; Xu X; Bass A; Chandar AK; Chak A; Elliott R; Willis JE; Markowitz SD; Grady WM
    Gut; 2019 Mar; 68(3):389-399. PubMed ID: 29884612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of Mutations in Barrett's Esophagus Before Progression to High-Grade Dysplasia or Adenocarcinoma.
    Stachler MD; Camarda ND; Deitrick C; Kim A; Agoston AT; Odze RD; Hornick JL; Nag A; Thorner AR; Ducar M; Noffsinger A; Lash RH; Redston M; Carter SL; Davison JM; Bass AJ
    Gastroenterology; 2018 Jul; 155(1):156-167. PubMed ID: 29608884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of major molecular alterations during progression from Barrett's esophagus to esophageal adenocarcinoma.
    Kalatskaya I
    Ann N Y Acad Sci; 2016 Oct; 1381(1):74-91. PubMed ID: 27415609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Esophageal microbiome signature in patients with Barrett's esophagus and esophageal adenocarcinoma.
    Lopetuso LR; Severgnini M; Pecere S; Ponziani FR; Boskoski I; Larghi A; Quaranta G; Masucci L; Ianiro G; Camboni T; Gasbarrini A; Costamagna G; Consolandi C; Cammarota G
    PLoS One; 2020; 15(5):e0231789. PubMed ID: 32369505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D receptor is highly expressed in precancerous lesions and esophageal adenocarcinoma with significant sex difference.
    Zhou Z; Xia Y; Bandla S; Zakharov V; Wu S; Peters J; Godfrey TE; Sun J
    Hum Pathol; 2014 Aug; 45(8):1744-51. PubMed ID: 24951052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Esophageal pepsin and proton pump synthesis in barrett's esophagus and esophageal adenocarcinoma.
    Samuels TL; Altman KW; Gould JC; Kindel T; Bosler M; MacKinnon A; Hagen CE; Johnston N
    Laryngoscope; 2019 Dec; 129(12):2687-2695. PubMed ID: 31046139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastroesophageal reflux and Barrett's esophagus: a pathway to esophageal adenocarcinoma.
    Schlottmann F; Molena D; Patti MG
    Updates Surg; 2018 Sep; 70(3):339-342. PubMed ID: 30039277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.